TeamViewer (TMV) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
3 Nov, 2026Executive summary
Q3 revenue was €184.5m (-2.2% YoY cc) and ARR was €736.9m (-0.6% cc); Enterprise platform momentum strengthened while SMB trends stabilized.
FY 2026 revenue growth guidance was cut to -2% to -1% cc; adjusted EBITDA margin guidance of ~43% was reaffirmed.
Financial highlights
Q3 revenue was €184.5m, down 4% reported versus €192.0m pro forma; adjusted EBITDA was €78.9m, down 10% YoY, with a 42.8% margin.
Gross profit was €167.8m at a 91% margin; EBIT was €63.3m, down 4%.
Net income rose 26% to €36.0m; adjusted EPS was €0.27, down 19% YoY.
Adjusted levered free cash flow was €27.3m, up 29%; adjusted cash conversion improved to 35% from 24%.
Outlook and guidance
FY 2026 revenue growth guidance was lowered to -2% to -1% YoY cc from 0% to 3%; adjusted EBITDA margin guidance remained ~43%.
Delayed Enterprise deal conversion and renewed European uncertainty weighed on the outlook; improved U.S. Enterprise momentum and EMEA sales scaling are expected to support ARR growth in 2027.
Q&A estimates indicated Q4 Enterprise ARR growth of 2%–3% and total ARR exit growth of -2% to 0%; these were directional, not formal guidance.
Latest events from TeamViewer
- DEX turnaround, enterprise growth, and ServiceNow partnership support FY guidance reaffirmation.TMV
Q2 2026 - Enterprise ARR up 8% cc, profitability strong, and guidance reaffirmed for 2026.TMV
Q1 2026 - 5% revenue and 8% EBITDA growth in 2025; 2026 outlook cautious with 0–3% growth target.TMV
Q4 2025 - Q2 revenue up 6% and adjusted EBITDA up 17%, driven by enterprise gains and new product launches.TMV
Q2 2025 - $720M deal creates a DEX leader, targeting double-digit growth and global expansion by 2027.TMV
M&A Announcement - Enterprise momentum and cost discipline drove strong Q3 growth and profitability.TMV
Q3 2024 - Q2 2024 delivered strong growth, high margins, and reaffirmed full-year guidance.TMV
Q2 2024 - Enterprise ARR up 21%, revenue and EBITDA both rise 7% and 20% year-over-year, outlook confirmed.TMV
Q1 2025 - FY 2024 exceeded guidance with strong Enterprise growth, 1E integration, and margin expansion.TMV
Q4 2024